Morey-Hype and Civil Aviation Safety Authority

This matter concerned an appeal by the applicant, Mr Morey-Hype, against a decision by the Civil Aviation Safety Authority (CASA) to issue him with Class 1 and Class 2 medical certificates subject to certain conditions. The applicant had previously held these certificates continuously since 1995/1996, despite sustaining a significant spinal injury in 1993 and later being diagnosed with bowel cancer and chronic pain syndrome. The central dispute revolved around CASA's imposition of conditions on the applicant's medical certificates, which he sought to have removed. The decision was made by A Poljak SM.

The primary legal issue before the court was whether the applicant's ongoing pain management, particularly his use of opiate-based medication such as Panadeine Forte, posed a risk to aviation safety. The court was required to consider if the conditions imposed by CASA were necessary to ensure the safety of air navigation, as mandated by regulation 11.056 of the Civil Aviation Safety Regulations 1998 (Cth), and whether the applicant's medical condition and treatment impacted his ability to control an aircraft. CASA conceded that alleged issues with obstructive sleep apnoea and a mental health condition were not relevant to these proceedings.

The court reasoned that while the applicant was an exceptional pilot with an impeccable flying record, the paramount consideration was the safety of air navigation, as stipulated by section 9A of the Civil Aviation Act 1988 (Cth). The court noted that the relevant medical standards, set out in Part 67 of CASR, require that a pilot must not have any safety-relevant condition or be using medication that causes safety-relevant side-effects. Despite the applicant's contention that his long history of holding a medical certificate and his ability to manage his pain demonstrated no adverse effects, the court ultimately agreed with CASA's decision to impose conditions. The court found that the conditions, which included limitations on flight duration, specific training activities, and a 12-hour exclusion period after using opiate-based medication, provided the necessary assurance for aviation safety.

The court affirmed CASA's decision of 29 February 2016, which issued the applicant with Class 1 and Class 2 Medical Certificates subject to the specified conditions. This decision replaced an earlier cancellation decision from 13 April 2015, and the Tribunal found no utility in reviewing the earlier decision. The applicant's request to have the conditions removed was therefore dismissed.